NASDAQ: INTC
INTEL CORPCIK 0000050863 · SIC 3674 · Semiconductors
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (GIS 10-Q) is open in full — no account needed.
Intel raises $19.7B net in common stock offering, upsized to $20B gross at $95/share
4 material changes detected. Sign up free to read the summary.
Intel prices $19.7B follow-on offering at $97.52/share for capex and working capital
4 material changes detected. Sign up free to read the summary.
Partner
Trade INTC commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Intel offering common stock at market; size and price not disclosed in preliminary 424B5
4 material changes detected. Sign up free to read the summary.
Q2 2026: revenue $16.1B, net income -$11.0B. Revenue +25% on premium mix, but net loss widens 278% on escrow charge
5 material changes detected. Sign up free to read the summary.
Intel reports Q2 revenue up 25% YoY to $16.1B, GAAP loss of $(2.16)/share on CHIPS Act charge
5 material changes detected. Sign up free to read the summary.
Intel stockholders approve executive pay, equity plans at annual meeting
4 material changes detected. Sign up free to read the summary.
Intel raises $6.5B in debt across five tranches with rates up to 6.2% for 40-year bonds
5 material changes detected. Sign up free to read the summary.
Intel's Chief Accounting Officer Scott Gawel resigns immediately; CFO takes dual role
2 material changes detected. Sign up free to read the summary.
revenue $13.6B, net income -$3.73B. Intel posts Mobileye impairment as Iran conflict threatens Israel fab, 14A node at risk
5 material changes detected. Sign up free to read the summary.
Intel reports Q1 2026 earnings and Q2 guidance in routine quarterly disclosure
2 material changes detected. Sign up free to read the summary.
Intel repurchases Apollo's 49% Fab 34 stake for $14.2B, adds $6.5B bridge debt
4 material changes detected. Sign up free to read the summary.
revenue $52.9B, net income -$267.0M. Intel, equity sales; divests Altera; warns supply constraints persist
5 material changes detected. Sign up free to read the summary.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Jul 24, 2026 (period ending Jun 27, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Consolidated Condensed Statements of Operations
(In Millions, Except Per Share Amounts; Unaudited)
| Description | Three months ended Jun 27, 2026 | Three months ended Jun 28, 2025 | Six months ended Jun 27, 2026 | Six months ended Jun 28, 2025 |
|---|---|---|---|---|
| Net revenue | 16,128 | 12,859 | 29,705 | 25,526 |
| Cost of sales | 9,619 | 9,317 | 17,849 | 17,312 |
| Gross profit | 6,509 | 3,542 | 11,856 | 8,214 |
| Research and development | 3,368 | 3,684 | 6,743 | 7,324 |
| Marketing, general, and administrative | 1,175 | 1,144 | 2,213 | 2,321 |
| Restructuring and other charges | 170 | 1,890 | 4,240 | 2,046 |
| Operating expenses | 4,713 | 6,718 | 13,196 | 11,691 |
| Operating income (loss) | 1,796 | (3,176) | (1,340) | (3,477) |
| Gains (losses) on equity investments, net | (39) | 502 | (111) | 390 |
| Interest and other, net | (12,576) | (95) | (13,314) | (268) |
| Income (loss) before taxes | (10,819) | (2,769) | (14,765) | (3,355) |
| Provision for (benefit from) taxes | 29 | 255 | 364 | 556 |
| Net income (loss) | (10,848) | (3,024) | (15,129) | (3,911) |
| Less: net income (loss) attributable to non-controlling interests | 185 | (106) | (368) | (172) |
| Net income (loss) attributable to Intel | (11,033) | (2,918) | (14,761) | (3,739) |
| Earnings (loss) per share attributable to Intel—basic | (2.16) | (0.67) | (2.89) | (0.86) |
| Earnings (loss) per share attributable to Intel—diluted | (2.16) | (0.67) | (2.89) | (0.86) |
| Weighted average shares of common stock outstanding: | ||||
| Basic | 5,104 | 4,369 | 5,108 | 4,356 |
| Diluted | 5,104 | 4,369 | 5,108 | 4,356 |
Consolidated Condensed Balance Sheets
(In Millions; Unaudited)
| Description | Jun 27, 2026 | Dec 27, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | 12,874 | 14,265 |
| Short-term investments | 16,853 | 23,151 |
| Accounts receivable, net | 4,033 | 3,839 |
| Inventories | 12,492 | 11,618 |
| Other current assets | 10,961 | 10,815 |
| Total current assets | 57,213 | 63,688 |
| Property, plant, and equipment, net of accumulated depreciation of $109,918 ($106,464 as of December 27, 2025) | 105,741 | 105,414 |
| Equity investments | 8,410 | 8,512 |
| Goodwill | 20,465 | 23,912 |
| Identified intangible assets, net | 2,545 | 2,772 |
| Other long-term assets | 8,065 | 7,131 |
| Total assets | 202,439 | 211,429 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | 8,756 | 9,882 |
| Accrued compensation and benefits | 3,748 | 3,990 |
| Short-term debt | 1,988 | 2,499 |
| Other accrued liabilities | 21,178 | 15,204 |
| Total current liabilities | 35,670 | 31,575 |
| Debt | 48,549 | 44,086 |
| Other long-term liabilities | 15,077 | 9,408 |
| Contingencies (Note 14) | ||
| Stockholders’ equity: | ||
| Common stock and capital in excess of par value, 5,043 issued and outstanding (4,994 issued and outstanding as of December 27, 2025) | 53,780 | 65,185 |
| Accumulated other comprehensive income (loss) | (80) | 113 |
| Retained earnings | 33,842 | 48,983 |
| Total Intel stockholders' equity | 87,542 | 114,281 |
| Non-controlling interests | 15,601 | 12,079 |
| Total stockholders' equity | 103,143 | 126,360 |
| Total liabilities and stockholders’ equity | 202,439 | 211,429 |
Consolidated Condensed Statements of Cash Flows
(In Millions; Unaudited)
| Description | Six months ended Jun 27, 2026 | Six months ended Jun 28, 2025 |
|---|---|---|
| Cash, cash equivalents, and restricted cash, beginning of period | 14,712 | 8,249 |
| Cash flows provided by (used for) operating activities: | ||
| Net income (loss) | (15,129) | (3,911) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||
| Depreciation | 5,891 | 5,213 |
| Share-based compensation | 1,307 | 1,348 |
| Restructuring and other charges | 3,967 | 382 |
| Amortization of intangibles | 469 | 474 |
| (Gains) losses on equity investments, net | 111 | (390) |
| Mark-to-market (gains) losses on Escrowed Shares | 13,619 | — |
| Deferred taxes | (27) | 106 |
| Impairments and net (gain) loss on retirement of property, plant, and equipment | 165 | 482 |
| Changes in assets and liabilities: | ||
| Accounts receivable | (221) | 1,004 |
| Inventories | (874) | 99 |
| Accounts payable | 310 | 114 |
| Accrued compensation and benefits | (372) | 1,022 |
| Income taxes | (477) | (1,338) |
| Other assets and liabilities | (637) | (1,742) |
| Total adjustments | 23,231 | 6,774 |
| Net cash provided by (used for) operating activities | 8,102 | 2,863 |
| Cash flows provided by (used for) investing activities: | ||
| Additions to property, plant, and equipment | (6,192) | (8,733) |
| Proceeds from capital-related government incentives | 167 | 964 |
| Acquisitions, net of cash acquired | (596) | — |
| Purchases of short-term investments | (12,737) | (5,730) |
| Sales of short-term investments | 11,009 | 1,948 |
| Maturities of short-term investments | 7,724 | 6,627 |
| Proceeds from divestitures, net | — | 1,935 |
| Other investing | (44) | 984 |
| Net cash provided by (used for) investing activities | (669) | (2,005) |
| Cash flows provided by (used for) financing activities: | ||
| Issuance of commercial paper, net of issuance costs | — | 3,493 |
| Repayment of commercial paper | — | (1,496) |
| Payments on finance leases | (832) | (9) |
| Partner contributions | 4,082 | 2,238 |
| Partner distributions | (14,339) | (91) |
| Additions to property, plant, and equipment | (1,423) | (1,962) |
| Issuance of term debt, net of issuance costs | 13,000 | — |
| Repayment of term debt | (9,000) | (1,500) |
| Proceeds from sales of common stock through employee equity incentive plans | 427 | 491 |
| Restricted stock unit withholdings | (617) | (181) |
| Other financing | 154 | (397) |
| Net cash provided by (used for) financing activities | (8,548) | 586 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | (1,115) | 1,444 |
| Cash, cash equivalents, and restricted cash, end of period1 | 13,597 | 9,693 |
Amounts as printed on the EDGAR/iXBRL face — (In Millions, Except Per Share Amounts; Unaudited); (In Millions; Unaudited). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗